Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

TOKYO, Oct 16 (Reuters): Fujifilm Holdings Corp has announced that it was seeking approval for its flu drug Avigan as a treatment for Covid-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.

Shares of the company closed roughly 3% higher on the news.

The Nikkei newspaper last month cited https://asia.nikkei.com/Spotlight/Coronavirus/Japanese-approval-sought-for-Avigan-to-treat-Covid-19 ministry sources saying approval could be granted to the drug within a month of its application.

Japan has already approved Avigan, known generically as favipiravir, as an emergency flu medicine, which is the subject of at least 16 clinical trials around the world. But concerns remain, as the drug has been shown to cause birth defects in animal studies.

Japan's government has called on Fujifilm to triple national stockpiles of the drug. The company said in a statement it has been working with strategic partners to meet that goal and requests by other countries to supply the drug.

Fujifilm in July signed a deal with India's Dr Reddy's Laboratories and Dubai-based Global Response Aid to sell Avigan for Covid-19 globally, excluding in China, Japan and Russia. The drug has been approved to treat Covid-19 in India and Russia.

Last month, Fujifilm said the late-stage study of 156 Covid-19 patients in Japan showed that symptoms of those treated with Avigan improved after 11.9 days, versus 14.7 days for a placebo group.

Results of the study, conducted by subsidiary Fujifilm Toyama Chemical, were found to be statistically significant. - Reuters
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Did you find this article insightful?


50% readers found this article insightful

Next In Aseanplus News

AstraZeneca likely to run new global trial on Covid-19 vaccine
PAL's US$5bil debt rehab largest in Philippines history
Thailand to open up to 1,200 visitors soon
China's economic growth to be driven by consumption
Crowds in Orchard Road on Black Friday sales even as sales move online
Pig guts fly in Taiwan parliament protest
Biker dog Bogie cruises Philippine highways
Hong Kong, Singapore office REITs live on in post-virus world
Covid-19: Japan to start new round of tests on 15,000 people
Bangkok launches eco-friendly electric boats on canal

Stories You'll Enjoy